Loading patent…
AssigneeQu Biologics Inc.
InventorsHarold David Gunn, Salim Dhanji, Brett Anthony Premack, Michael Tak Huai Chow
Estimating the term…
The invention provides methods of treating inflammation in a specific organ or tissue of an individual. The method involves determining whether the individual has previously been infected with at least one pathogen that is pathogenic in the specific organ or tissue; and administering to the individual an anti-inflammatory composition comprising antigenic determinants, the antigenic determinants selected or formulated so that together they are specific for the at least one pathogen. The pathogen may be an endogenous or exogenous pathogen, and may further be a bacterial pathogen, a viral pathogen, a fungal pathogen, a protozoan pathogen, or a helminth pathogen.
1-20. (canceled)
A method of provoking an immune response in an inflammatory bowel disease (IBD) patient by intradermal or subcutaneous injection of a formulation consisting essentially of whole killed E. coli cells, wherein the formulation is administered by repeated subcutaneous or intradermal injection at least every other day for at least two weeks.
Dependencies are inferred from the claim text.